• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本耐甲氧西林金黄色葡萄球菌的影响。

Effect of methicillin-resistant Staphylococcus aureus in Japan.

机构信息

Department of Healthcare Economics and Quality Management, Graduate School of Medicine, Kyoto University, Kyoto City, Kyoto, Japan.

Department of Bacteriology II, National Institute of Infectious Diseases, Musashimurayama City, Tokyo, Japan.

出版信息

Am J Infect Control. 2018 Oct;46(10):1142-1147. doi: 10.1016/j.ajic.2018.04.214. Epub 2018 May 18.

DOI:10.1016/j.ajic.2018.04.214
PMID:29784441
Abstract

BACKGROUND

Methicillin-resistant Staphylococcus aureus (MRSA) is the most common antimicrobial-resistant organism identified in Japanese health care facilities. This study analyzed the clinical and economic burdens attributable to methicillin resistance in S aureus in Japanese hospitals.

METHODS

We retrospectively investigated data from 14,905 inpatients of 57 hospitals combined with data from nosocomial infection surveillance and administrative claim databases. The participants were inpatients with admission from April 1, 2014, to discharge on March 31, 2016. The outcomes were evaluated according to length of stay, hospital charges, and in-hospital mortality. We compared the disease burden of MRSA infections with methicillin-susceptible S aureus (MSSA) infections based on patients' characteristics and onset periods.

RESULTS

We categorized 7,188 and 7,717 patients into MRSA and MSSA groups, respectively. The adjusted effects of the MRSA group were 1.03-fold (95% confidence interval [CI] 1.01-1.05) and 1.04-fold (95% CI, 1.01-1.06), respectively, with an odds ratio of 1.14 (95% CI, 1.02-1.27).

CONCLUSIONS

The results of this study found that patient severity and onset delays were positively associated with both MRSA and burden and that the effect of methicillin resistance remained significant after adjustment.

摘要

背景

耐甲氧西林金黄色葡萄球菌(MRSA)是日本医疗机构中最常见的抗微生物药物耐药菌。本研究分析了日本医院中金黄色葡萄球菌耐甲氧西林的临床和经济负担。

方法

我们回顾性调查了来自 57 家医院的 14905 名住院患者的数据,同时结合了医院感染监测和行政索赔数据库的数据。参与者为 2014 年 4 月 1 日至 2016 年 3 月 31 日期间入院的住院患者。根据住院时间、医院费用和院内死亡率来评估结局。我们根据患者特征和发病期比较了 MRSA 感染和甲氧西林敏感金黄色葡萄球菌(MSSA)感染的疾病负担。

结果

我们将 7188 名和 7717 名患者分别归入 MRSA 和 MSSA 组。MRSA 组的调整后影响为 1.03 倍(95%置信区间[CI] 1.01-1.05)和 1.04 倍(95% CI,1.01-1.06),比值比为 1.14(95% CI,1.02-1.27)。

结论

本研究结果发现,患者严重程度和发病延迟与 MRSA 和负担均呈正相关,并且在调整后,耐甲氧西林的影响仍然显著。

相似文献

1
Effect of methicillin-resistant Staphylococcus aureus in Japan.日本耐甲氧西林金黄色葡萄球菌的影响。
Am J Infect Control. 2018 Oct;46(10):1142-1147. doi: 10.1016/j.ajic.2018.04.214. Epub 2018 May 18.
2
Excess costs and utilization associated with methicillin resistance for patients with Staphylococcus aureus infection.耐甲氧西林金黄色葡萄球菌感染患者相关的超额费用和利用
Infect Control Hosp Epidemiol. 2010 Apr;31(4):365-73. doi: 10.1086/651094.
3
Are there differences in hospital cost between patients with nosocomial methicillin-resistant Staphylococcus aureus bloodstream infection and those with methicillin-susceptible S. aureus bloodstream infection?耐甲氧西林金黄色葡萄球菌医院血流感染患者与甲氧西林敏感金黄色葡萄球菌血流感染患者之间的住院费用有差异吗?
Infect Control Hosp Epidemiol. 2009 May;30(5):453-60. doi: 10.1086/596731.
4
Estimating the disease burden of methicillin-resistant Staphylococcus aureus in Japan: Retrospective database study of Japanese hospitals.日本耐甲氧西林金黄色葡萄球菌疾病负担的估算:日本医院的回顾性数据库研究
PLoS One. 2017 Jun 27;12(6):e0179767. doi: 10.1371/journal.pone.0179767. eCollection 2017.
5
Methicillin resistance in Staphylococcus aureus infections among patients colonized with methicillin-susceptible Staphylococcus aureus.耐甲氧西林金黄色葡萄球菌感染患者中对甲氧西林敏感金黄色葡萄球菌定植的耐甲氧西林金黄色葡萄球菌感染。
Clin Microbiol Infect. 2019 Jan;25(1):71-75. doi: 10.1016/j.cmi.2018.03.045. Epub 2018 Apr 10.
6
Comparing methods to estimate incremental inpatient costs and length of stay due to methicillin-resistant Staphylococcus aureus in Alberta, Canada.比较加拿大艾伯塔省估算耐甲氧西林金黄色葡萄球菌所致住院增量成本和住院时间的方法。
BMC Health Serv Res. 2019 Oct 24;19(1):743. doi: 10.1186/s12913-019-4578-z.
7
Adverse Clinical Outcomes and Resource Utilization Associated with Methicillin-Resistant and Methicillin-Sensitive Staphylococcus aureus Infections after Elective Surgery.择期手术后耐甲氧西林金黄色葡萄球菌和甲氧西林敏感金黄色葡萄球菌感染相关的不良临床结局及资源利用情况
Surg Infect (Larchmt). 2015 Oct;16(5):543-52. doi: 10.1089/sur.2013.250. Epub 2015 Jun 30.
8
Increasing role of Staphylococcus aureus and community-acquired methicillin-resistant Staphylococcus aureus infections in the United States: a 10-year trend of replacement and expansion.在美国,金黄色葡萄球菌和社区获得性耐甲氧西林金黄色葡萄球菌感染的作用不断增加:替代和扩张的 10 年趋势。
Microb Drug Resist. 2011 Jun;17(2):321-8. doi: 10.1089/mdr.2010.0193. Epub 2011 Mar 19.
9
Length of stay, hospitalisation costs and in-hospital mortality of methicillin-susceptible and methicillin-resistant Staphylococcus aureus bacteremia in Japan.日本耐甲氧西林敏感金黄色葡萄球菌和耐甲氧西林金黄色葡萄球菌菌血症的住院时间、住院费用和住院死亡率。
Public Health. 2021 Sep;198:292-296. doi: 10.1016/j.puhe.2021.07.046. Epub 2021 Sep 7.
10
Is methicillin-resistant Staphylococcus aureus more virulent than methicillin-susceptible S. aureus? A comparative cohort study of British patients with nosocomial infection and bacteremia.耐甲氧西林金黄色葡萄球菌比甲氧西林敏感金黄色葡萄球菌的毒力更强吗?一项针对英国医院感染和菌血症患者的比较队列研究。
Clin Infect Dis. 2003 Dec 1;37(11):1453-60. doi: 10.1086/379321. Epub 2003 Nov 6.

引用本文的文献

1
Healthcare utilization associated with antimicrobial resistance at a tertiary hospital in Vietnam: A retrospective observational study from 2016 to 2021.越南一家三级医院与抗菌药物耐药性相关的医疗服务利用情况:一项2016年至2021年的回顾性观察研究。
PLoS One. 2025 Aug 4;20(8):e0329539. doi: 10.1371/journal.pone.0329539. eCollection 2025.
2
Detection and genetic characterization of multidrug-resistant staphylococci isolated from public areas in an international airport.从国际机场公共区域分离的耐多药葡萄球菌的检测和遗传特征分析。
Sci Rep. 2024 Nov 12;14(1):27738. doi: 10.1038/s41598-024-79447-3.
3
Burden of Antimicrobial Resistance in Japan: A Systematic Literature Review and Meta-Analysis.
日本抗菌药物耐药性负担:系统文献综述与荟萃分析
Infect Dis Ther. 2024 May;13(5):1105-1125. doi: 10.1007/s40121-024-00960-z. Epub 2024 Apr 25.
4
Comparison of disease and economic burden between MRSA infection and MRSA colonization in a university hospital: a retrospective data integration study.比较一所大学医院中耐甲氧西林金黄色葡萄球菌(MRSA)感染与定植的疾病和经济负担:一项回顾性数据整合研究。
Antimicrob Resist Infect Control. 2024 Feb 29;13(1):27. doi: 10.1186/s13756-024-01383-8.
5
The economic burden of antibiotic resistance: A systematic review and meta-analysis.抗生素耐药性的经济负担:系统评价和荟萃分析。
PLoS One. 2023 May 8;18(5):e0285170. doi: 10.1371/journal.pone.0285170. eCollection 2023.
6
Estimated medical costs of methicillin-resistant infection classified by polymerase chain reaction-based open reading frame typing in Japan.日本基于聚合酶链反应的开放阅读框分型法对耐甲氧西林感染的预估医疗费用。
AIMS Microbiol. 2022 Dec 19;8(4):528-543. doi: 10.3934/microbiol.2022034. eCollection 2022.
7
Cost and healthcare utilization of methicillin-resistant bacteremia estimated from linked antimicrobial resistance surveillance and hospital claims data in Japan.根据日本抗菌药物耐药性监测与医院报销数据估算耐甲氧西林菌血症的成本及医疗资源利用情况
Antimicrob Steward Healthc Epidemiol. 2022 Aug 30;2(1):e147. doi: 10.1017/ash.2022.280. eCollection 2022.
8
Relationship between mortality and molecular epidemiology of methicillin-resistant Staphylococcus aureus bacteremia.耐甲氧西林金黄色葡萄球菌菌血症的死亡率与分子流行病学之间的关系。
PLoS One. 2022 Jul 8;17(7):e0271115. doi: 10.1371/journal.pone.0271115. eCollection 2022.
9
A Strategy for Hospital Pharmacists to Control Antimicrobial Resistance (AMR) in Japan.日本医院药剂师控制抗菌药物耐药性(AMR)的策略。
Antibiotics (Basel). 2021 Oct 21;10(11):1284. doi: 10.3390/antibiotics10111284.
10
Healthcare resources attributable to methicillin-resistant Staphylococcus aureus orthopedic surgical site infections.耐甲氧西林金黄色葡萄球菌骨科手术部位感染相关的医疗资源。
Sci Rep. 2020 Oct 13;10(1):17059. doi: 10.1038/s41598-020-74070-4.